Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Doctors' Experience with Handheld Computers in Clinical Practice: Qualitative Study
BMJ 328:1162-1165, McAlearney,A.S.,et al, 2004
Handheld Computers
BMJ 328:1181-1184, Al-Ubaydli,M., 2004
Basal Ganglia Hyperperfusion in a Patient with Systemic Lupus Erythematosus-Related Parkinsonism
Neurol 63:395-396, Lee,P.H.,et al, 2004
Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004
Serial 18F-fluoro-2-deoxy-D-glucose Positron Emmission Tomography and Magnetic Resonance Imaging of Paraneoplastic Limbic Encephalitis
Arch Neurol 61:1785-1789, Scheid,R.,et al, 2004
Expert Medical Testimony: Responsibilities of Medical Societies
Neurol 63:1557-1558, Freeman,J.M. &Nelson,K.B., 2004
Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004
Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004
Are Your Patients Getting the Information They Need?
Neurol 61:3126-1327, Jankowiak,J. &Brey,R.L., 2003
Complementary/Alternative Medicine for Epilepsy in Arizona
Neurol 61:576-577, Sirven,J.I.,et al, 2003
Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003
Best Measure of Ischemic Penumbra: Positron Emission Tomography
Stroke 34:2534-2535, Heiss,W.-D., 2003
Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain
JAMA 290:1757-1762, Karst,M.,et al, 2003
Information Technology, The Internet, and The Future of Neurology
The Neurologist 9:149-159, Maulden,S.A., 2003
Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003
Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients
BMJ 326:21, Maas,R.,et al, 2003
Prenatal Diagnosis Requests for Huntington's Disease when the Father is at Risk, and Does Not Want to Know His Genetic Status: Clinical, Legal, and Ethical Viewpoints
BMJ 326:331-333, Tassicker,R.,et al, 2003
Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003
A Study of Persistent Post-Concussion Symptoms in Mild Head Trauma Using Positron Emission Tomogrophy
JNNP 74:326-332, Chen,S.H.A.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Quantitative Sensory Testing, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 60:898-904, Shy,M.E.,et al, 2003
The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003
The Internet
JNNP 73:619-628, Al-Shahi,R.,et al, 2002
The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Genseng, Echinacea, Saw Palmetto, and Kava
Ann Int Med 136:42-53, Ernst,E., 2002
Functional Brain Mapping of Psychopathology
JNNP 72:432-439, Honey,G.D.,et al, 2002
Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002
Responding to Medical Events During Commercial Airline Flights
NEJM 346:1067-1073, Gendreau,M.A. &DeJohn,C., 2002
The Late Whiplash Syndrome: A Biopsychosocial Approach
JNNP 70:722-726, Ferrari,R. &Schrader,H., 2001
F-Fluorodeoxyglucose Positron Emission Tomography and MR Imaging Findings in Rasumussen Encephalitis
AJNR 22:1291-1299, Fiorella,D.J.,et al, 2001
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
[123I]Beta-CIT SPECT Imaging Assessment of the Rate of Parkinson's Disease Progression
Neurol 57:2089-2094, Marek,K.,et al, 2001
Individual State Driving Restrictions for People With Epilepsy in the US
Neurol 57:1780-1785,1749, Krauss,G.L.,et al, 2001
How Neurologists Can Enhance Patient-Centered Medicine
Neurol 56:144-145, Berant,J.L., 2001
Chorea and Antiphospholipid Antibodies: Treatment with Methotrexate
Neurol 56:137-138, Paus,S.,et al, 2001
Functional Correlates of Pallidal Stimulation for Parkinson's Disease
Ann Neurol 49:155-164,142, Fukuda,M.,et al, 2001
Diffusion-weighted MR Imaging in a Case of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes
AJNR 22:269-272, Yonemura,K.,et al, 2001
Effect of Donepezil on Brain Acetylcholineserase Activity in Patients with AD Measured by PET
Neurol 56:408-410, Shinotoh,H.,et al, 2001
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
NEJM 344:710-719,763, Freed,C.R.,et al, 2001
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Malpractice Claims: Outcome Evidence to Guide Neurologic Education?
Neurol 56:1099-1100,991, Glick,T.H., 2001
The Frequency of Carpal Tunnel Syndrome in Computer Users at a Medical Facility
Neurol 56:1568-1570, Clarke Stevens,J.,et al, 2001
Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001
The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
Arch Neurol 58:480-486, Bokde,A.L.W.,et al, 2001
Pharmacologic Paralysis and Withdrawal of Mechanical Ventilation at the End of Life
NEJM 342:508-511, Truog,R.D.,et al, 2000
Striatal Dopamine Trnasporter Binding Assessed by [I-123]IPT and Single Photon Emission Computed tomography in Patients with Early Parkinson's Disease, Implications for a Preclinical Diagnosis
Arch Neurol 57:205-208, Schwarz,J.,et al, 2000
Role of Brain Biopsy in the Management of Focal Brain Lesions in HIV-Infected Patients
Neurol 54:993-997, Antinori,A.,et al, 2000
Whiplash
Arch Neurol 57:590-591,594, Bogduk,N.,&Teasell,R., 2000
Chronic Whiplash Syndrome as a Functional Disorder
Arch Neurol 57:592-594, Berry,H., 2000
Effect of Eliminating Compensation for Pain and Suffering on the Outcome of Insurance Claims for Whiplash Injury
NEJM 342:11790-1186,1211, Cassidy,J.D.,et al, 2000